HLF is a promising prognostic, immunological, and therapeutic biomarker in human tumors
Abstract Despite past research linking HLF mutations to cancer development, no pan-cancer analyses of HLF have been published. As a…
Abstract Despite past research linking HLF mutations to cancer development, no pan-cancer analyses of HLF have been published. As a…
Abstract Background: Colorectal cancer (CRC) is a solid tumor with high morbidity and mortality rates. Accumulating evidence shows that the…
Abstract Growing evidence has shown the oncogenic function of matrix metallopeptidase 7 (MMP7) in various tumors. However, no systemic pan-cancer…
Abstract Objectives: Potassium Calcium-Activated Channel Subfamily N Member 4 (KCNN4) is a member of the KCNN family. Studies have revealed…
Abstract Background: ZFPM2-AS1, as an oncogenic lncRNA, plays an essential role in the progression of several tumors. However, the prognostic…
Abstract Although immunotherapy has recently demonstrated a substantial promise in treating advanced thyroid carcinoma (THCA), it is not appropriate for…
Abstract Stromal and immune cells are major components of tumor microenvironment (TME) and affect the growth and development of thyroid…
Abstract Transporter associated with antigen processing 1 (TAP1) is a protein related immune regulation and plays a role in several…
Abstract Background: Identifying a unique and common regulatory pathway that drives tumorigenesis in cancers is crucial to foster the development…
Abstract Human leukocyte antigen G (HLA-G) is known as a novel immune checkpoint molecule in cancer; thus, HLA-G and its…